PATRICK NAKASHIMA-MORAN: Open Payments
NPI 1558743138 · O FALLON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 25 payments from 12 companies in 2025. Trend: 2023 $802 · 2024 $733 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $151 |
| Novo Nordisk Inc | 4 | $65 |
| Lilly USA, LLC | 3 | $61 |
| PFIZER INC. | 3 | $58 |
| ABBVIE INC. | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 3 | $53 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $21 |
| Abbott Laboratories | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: AREXVY, PREVNAR 20, SPRAVATO, MOUNJARO, LINZESS, Rybelsus, Wegovy, TRELEGY ELLIPTA.
Industry payments across IL — which companies pay providers there.
